
Releases
Huntington’s Disease Market Forecasted to Grow at 14% CAGR Through 2036
The global market for Huntington's disease therapies is bracing for a decade of transformation, with projections indicating a 14% compound annual growth rate through 2036. As current treatments remain largely limited to symptomatic relief, a pipeline of disease-modifying candidates aims to shift the standard of care.


























